http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2188680-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88b6445cd1d147b5a0c19551478764b2
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067
filingDate 2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13cb1e5f8e567072cd85d6e3765fd853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a90b9164f669e7304d078c080d60c59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa44a7a85c5917d24317e454886aa6f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73a9f5c6e01eeef4955f40a4be88e9bb
publicationDate 2002-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2188680-C1
titleOfInvention Method for treating antiphospholipid syndrome
abstract FIELD: medicine. SUBSTANCE: method involves exposing patient blood through the skin with low intensity infrared laser radiation of 0.89 mcm wavelength. Irradiation frequency is 1500 Hz, power flow density is equal to 1.25 mW/cm 2 . The radiation is combined with permanent magnetic field which magnetic induction is equal to 50 mTesla units. Subclavicular, ulnar, femoral and popliteal arteries are irradiated. Exposure time is selected in individual approach by taking into account dynamic changes of blood plasma refraction coefficient during the treatment course. EFFECT: enhanced effectiveness of treatment; allowed combination with medicaments. 2 cl
priorityDate 2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415816644
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114873

Total number of triples: 18.